La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris) emitió una alerta por la falsificación del medicamento oncológico Keytruda, utilizado para tratar a pacientes con melanoma metastásico o no removible y cáncer de pulmón.
Derivado de denuncias sanitarias presentadas por la farmacéutica Merck Sharp and Dohme Comercializadora S. de R.L. de C.V., el organismo gubernamental identificó nueve lotes de medicamentos irregulares, en la presentación solución de 100 mg/4 mL.
| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
